JPWO2021014957A1 - - Google Patents

Info

Publication number
JPWO2021014957A1
JPWO2021014957A1 JP2021533918A JP2021533918A JPWO2021014957A1 JP WO2021014957 A1 JPWO2021014957 A1 JP WO2021014957A1 JP 2021533918 A JP2021533918 A JP 2021533918A JP 2021533918 A JP2021533918 A JP 2021533918A JP WO2021014957 A1 JPWO2021014957 A1 JP WO2021014957A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533918A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021014957A1 publication Critical patent/JPWO2021014957A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
JP2021533918A 2019-07-22 2020-07-06 Pending JPWO2021014957A1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019134621 2019-07-22
PCT/JP2020/026483 WO2021014957A1 (ja) 2019-07-22 2020-07-06 ベンダムスチン注射液製剤

Publications (1)

Publication Number Publication Date
JPWO2021014957A1 true JPWO2021014957A1 (hr) 2021-01-28

Family

ID=74193839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533918A Pending JPWO2021014957A1 (hr) 2019-07-22 2020-07-06

Country Status (2)

Country Link
JP (1) JPWO2021014957A1 (hr)
WO (1) WO2021014957A1 (hr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015050230A1 (ja) * 2013-10-03 2015-04-09 富士フイルム株式会社 注射液製剤及びその製造方法
WO2018045136A1 (en) * 2016-08-31 2018-03-08 Navinta, Llc Bendamustine solution formulations
JP2018197248A (ja) * 2012-03-20 2018-12-13 イーグル・ファーマシューティカルズ・インコーポレーテッド 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法
JP2019099557A (ja) * 2017-11-28 2019-06-24 日本化薬株式会社 ベンダムスチンを含有する溶液製剤
JP2020090481A (ja) * 2018-11-27 2020-06-11 日本化薬株式会社 ベンダムスチンを含有する溶液製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914583C (en) * 2013-06-04 2019-06-18 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
JP7235288B2 (ja) * 2019-01-07 2023-03-08 コーアイセイ株式会社 ベンダムスチンの液体製剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018197248A (ja) * 2012-03-20 2018-12-13 イーグル・ファーマシューティカルズ・インコーポレーテッド 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法
WO2015050230A1 (ja) * 2013-10-03 2015-04-09 富士フイルム株式会社 注射液製剤及びその製造方法
WO2018045136A1 (en) * 2016-08-31 2018-03-08 Navinta, Llc Bendamustine solution formulations
JP2019099557A (ja) * 2017-11-28 2019-06-24 日本化薬株式会社 ベンダムスチンを含有する溶液製剤
JP2020090481A (ja) * 2018-11-27 2020-06-11 日本化薬株式会社 ベンダムスチンを含有する溶液製剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ポリエチレングリコール, JPN6023007852, 21 August 2019 (2019-08-21), ISSN: 0005007211 *

Also Published As

Publication number Publication date
WO2021014957A1 (ja) 2021-01-28

Similar Documents

Publication Publication Date Title
BR112019017762A2 (hr)
BR112021017339A2 (hr)
BR112021013854A2 (hr)
BR112021018450A2 (hr)
BR112021017939A2 (hr)
BR112021017892A2 (hr)
BR112019016141A2 (hr)
AU2020104490A4 (hr)
BR112021017738A2 (hr)
BR112021017782A2 (hr)
BR112019016142A2 (hr)
BR112019016138A2 (hr)
BR112021018168A2 (hr)
BR112021017234A2 (hr)
BR112021017355A2 (hr)
BR112021017173A2 (hr)
BR112021018102A2 (hr)
BR112021017083A2 (hr)
BR112021008711A2 (hr)
BR112021012348A2 (hr)
BR112021018084A2 (hr)
BR112021018093A2 (hr)
BR112021013944A2 (hr)
BR112021013128A2 (hr)
BR112021015080A2 (hr)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221219

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230307